NNovo Nordisk Read More FDA GLP-1 Compounding Proposal Boosts LLY, NVO, and HIMS Stock2026-05-07 Eli Lilly and Company NYSE: LLY and Novo Nordisk A/S NYSE: NVO are two weight-loss and diabetes drug…
NNovo Nordisk Read More Short Seller Who Bet Against Hims & Hers Now Says Its CEO ‘Wiped The Floor’ With Novo Nordisk2026-03-11 Hunterbrook had shorted Hims in 2024, warning its GLP-1 strategy relied on a regulatory loophole during drug shortages…